FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T17:03:54.209Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
Product / business disclosures (FY 2025)
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Product$92.94M
Service And Other Revenue$44.21M
License and Service$1.50M
Grant$243,000
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Reviewed labels link to their filing; other labels are unverified FMP source labels.
North America$49.09M
EMEA$28.67M
Asia Pacific$15.19M
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$32.91M
vs Estimate
$37.48M
Missed
QTRX Analyst Ratings
Consensus Rating
Hold
Based on 3 analysts
Strong Buy
0
Buy
0
Hold
3
Sell
0
Strong Sell
0
Average Price Target
$3.00
-13.4% downside
Low
$3.00
Current
$3.47
High
$3.00
QTRX Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Sep 2026
$-0.46
$-0.43
$-0.40
2
Quarter ending Dec 2026
$-0.45
$-0.37
$-0.33
3
Quarter ending Mar 2027
$-0.46
$-0.43
$-0.40
1
Quarter ending Jun 2027
$-0.36
$-0.34
$-0.32
1
Annual
Period
Low
Avg
High
# Analysts
FY 2026
$-2.28
$-2.25
$-2.23
1
FY 2027
$-1.25
$-1.24
$-1.23
1
Revenue Estimates
Quarterly
Period
Low
Avg
High
# Analysts
Quarter ending Sep 2026
$33.06M
$34.72M
$36.38M
2
Quarter ending Dec 2026
$37.90M
$39.80M
$41.70M
3
Quarter ending Mar 2027
$34.65M
$36.38M
$38.12M
1
Quarter ending Jun 2027
$35.39M
$37.17M
$38.94M
1
Annual
Period
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
